Company Analysis

Barinthus Biotherapeutics plc (BRNS)

BRNS · Pharmaceutical Preparations · Germantown, MD · filing with the SEC since 2020
Grade4.5
◀ Past 4.8● Present 5.1▶ Future 3.7
4 est.

Who runs Barinthus Biotherapeutics plc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Enright William
Chief Executive Officer. First filing Apr 2021, latest Sep 9, 2026, 1 filing in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
17 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Enright WilliamChief Executive OfficerApr 2021Sep 9, 2026none
Hooftman LeonChief Medical OfficerJun 2024Sep 9, 2026none
Swirsky Douglas JPrincipal Accounting OfficerMay 2026May 1, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dawes Karen AdirectorApr 2021Sep 9, 2026none
Hammacher AlexdirectorApr 2021Sep 9, 2026none
Morgon Pierre A.directorApr 2021Sep 9, 2026none
Phillips Anne M.directorApr 2021Sep 9, 2026none
Scheeren JosephdirectorApr 2021Sep 9, 2026none
Wright RobindirectorApr 2021Sep 9, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Oxford Sciences Innovation PLC10% ownerApr 2021Sep 11, 2026none
Earlier names on the record10, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BRNS · research, not advice